Vir Biotechnology, Inc. (VIR) Financials

VIR Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 1.8 billion 246.6 million
2023-12-31 2.0 billion 369.9 million
2023-09-30 2.0 billion 369.8 million
2023-06-30 2.2 billion 433.7 million

VIR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -111.3 million ?
2023-12-31 -109.5 million 28.3 million
2023-09-30 -159.5 million 26.9 million
2023-06-30 -398.7 million 30.6 million

VIR Net Income

No data available :(

VIR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 1.2 billion - -
2023-12-31 1.5 billion - 124.5 million
2023-09-30 1.7 billion - 114.1 million
2023-06-30 1.8 billion - 117.8 million

VIR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 135.3 million
2023-12-31 134.6 million
2023-09-30 134.3 million
2023-06-30 134.1 million

VIR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 1.9 million 100.1 million - -
2023-12-31 1.5 million 89.5 million 43.1 million -
2023-09-30 3.7 million 148.3 million 41.1 million -
2023-06-30 9.5 million 171.9 million 47.1 million -

VIR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 56.4 million 59000
2023-12-31 16.8 million 5.3 million
2023-09-30 -4.1 million 38000
2023-06-30 -12.7 million 22000

VIR

Price: $10.39

52 week price:
7.61
27.48

Earnings Per Share: -4.59 USD

P/E Ratio: -1.91

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 703157

Market Capitalization: 1.4 billion

Links: